Teva Donates Medicine to Haiti Earthquake Relief Effort
Jerusalem, Israel, January 19, 2010 - Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that it will be donating over $7 million in medicine to benefit earthquake victims in Haiti. Teva is working with several of its Non-Governmental Organization (NGO) partners to ensure these drugs are delivered to Haiti without delay.
"All of us at Teva were devastated to hear about the earthquake and our hearts and thoughts go out to the country of Haiti," said Shlomo Yanai, President and Chief Executive Officer of Teva Pharmaceutical Industries Ltd. "Working with our partners, we are providing essential medical products to assist in the relief efforts."
Teva, the largest generic pharmaceutical company in the world is proud to fulfill one of its leading values making quality medicine accessible around the world especially where and when it is needed most.
Teva will also match contributions made by its employees to designated charities around the world.
Teva Pharmaceutical Industries Ltd., headquartered in Israel, is among the top 15 pharmaceutical companies in the world and is the leading generic pharmaceutical company. The company develops, manufactures and markets generic and innovative pharmaceuticals and active pharmaceutical ingredients. Over 80 percent of Teva's sales are in North America and Western Europe.
Yossi Koren, 972 (3) 9268267
Teva Pharmaceutical Industries Ltd.
Denise Bradley, 215-591-8974
Teva North America